Trial · NCT00325403
Adverse events134
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 134
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | headache | Nervous system disorders | Placebo | 15 | 77 | 17 |
| other | headache | Nervous system disorders | UT-15C (Oral Treprostinil) | 95 | 151 | 131 |
| other | diarrhea | Gastrointestinal disorders | Placebo | 12 | 77 | 12 |
| other | diarrhea | Gastrointestinal disorders | UT-15C (Oral Treprostinil) | 46 | 151 | 54 |
| other | nausea | Gastrointestinal disorders | Placebo | 14 | 77 | 14 |
| other | nausea | Gastrointestinal disorders | UT-15C (Oral Treprostinil) | 45 | 151 | 50 |
| other | vomiting | Gastrointestinal disorders | Placebo | 12 | 77 | 12 |
| other | vomiting | Gastrointestinal disorders | UT-15C (Oral Treprostinil) | 26 | 151 | 31 |
| other | flushing | Vascular disorders | Placebo | 5 | 77 | 5 |
| other | flushing | Vascular disorders | UT-15C (Oral Treprostinil) | 23 | 151 | 25 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 6 | 77 | 6 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | UT-15C (Oral Treprostinil) | 21 | 151 | 25 |
| other | pain in jaw | Musculoskeletal and connective tissue disorders | Placebo | 3 | 77 | 3 |
| other | pain in jaw | Musculoskeletal and connective tissue disorders | UT-15C (Oral Treprostinil) | 17 | 151 | 18 |
| other | fatigue | General disorders | Placebo | 6 | 77 | 6 |
| other | fatigue | General disorders | UT-15C (Oral Treprostinil) | 14 | 151 | 15 |
| other | abdominal pain | Musculoskeletal and connective tissue disorders | Placebo | 4 | 77 | 4 |
| other | abdominal pain | Musculoskeletal and connective tissue disorders | UT-15C (Oral Treprostinil) | 13 | 151 | 13 |
| other | peripheral edema | Vascular disorders | Placebo | 5 | 77 | 5 |
| other | peripheral edema | Vascular disorders | UT-15C (Oral Treprostinil) | 13 | 151 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00325403/events